Nifty
:
23398.10
Sensex
:
74781.76
-79.70 (-0.34%)
-120.83 (-0.16%)
Nifty
Sensex
:
:
23398.10
74781.76
-79.70 (-0.34%)
-120.83 (-0.16%)

Sakar Healthcare Ltd.

Pharmaceuticals & Drugs

Rating :
74/99

BSE: Not Listed | NSE: SAKAR

NSE BSE
1158.55
11-Sep-2026
  • Open
  • High
  • Low
  • Previous Close
  •  1118
  •  1195
  •  1096.05
  •  1117.30
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  181225
  •  209424760.65
  •  1211
  •  330

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,577.76
  • 71.41
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,632.81
  • N/A
  • 7.70

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 52.52%
  • 2.11%
  • 19.96%
  • FII
  • DII
  • Others
  • 12.13%
  • 0.00%
  • 13.28%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 15.72
  • 13.39
  • 10.02

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 19.61
  • 17.06
  • 8.36

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 22.34
  • 10.38
  • 11.10

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 43.07
  • 54.24

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 2.97
  • 3.22

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 17.16
  • 19.35

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 26
Jun 25
Var%
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Net Sales
72.97
52.74
38.36%
71.10
50.24
41.52%
70.34
43.42
62.00%
57.56
42.78
34.55%
Expenses
51.72
40.03
29.20%
44.86
34.52
29.95%
51.75
31.66
63.46%
46.21
31.28
47.73%
EBITDA
21.25
12.71
67.19%
26.24
15.73
66.82%
18.59
11.76
58.08%
11.35
11.50
-1.30%
EBIDTM
29.12%
24.09%
36.90%
31.30%
26.43%
27.08%
19.73%
26.89%
Other Income
1.54
0.39
294.87%
0.17
0.18
-5.56%
0.51
0.30
70.00%
1.22
0.37
229.73%
Interest
1.67
2.14
-21.96%
2.41
4.19
-42.48%
1.77
1.30
36.15%
1.53
1.64
-6.71%
Depreciation
6.54
5.57
17.41%
5.94
5.48
8.39%
6.37
5.23
21.80%
5.68
5.12
10.94%
PBT
14.58
5.38
171.00%
18.06
6.24
189.42%
10.95
5.48
99.82%
5.36
5.11
4.89%
Tax
4.30
0.71
505.63%
7.03
0.48
1,364.58%
0.70
0.94
-25.53%
0.82
0.32
156.25%
PAT
10.29
4.67
120.34%
11.03
5.76
91.49%
10.25
4.53
126.27%
4.54
4.80
-5.42%
PATM
14.09%
8.86%
15.51%
11.47%
14.57%
10.44%
7.89%
11.21%
EPS
4.62
2.10
120.00%
4.95
2.62
88.93%
4.61
2.07
122.71%
2.04
2.21
-7.69%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Net Sales
271.97
177.58
153.35
133.36
128.23
94.74
82.98
Net Sales Growth
43.76%
15.80%
14.99%
4.00%
35.35%
14.17%
 
Cost Of Goods Sold
128.90
82.27
83.67
73.54
74.42
51.11
43.05
Gross Profit
143.07
95.32
69.67
59.81
53.80
43.63
39.93
GP Margin
52.60%
53.68%
45.43%
44.85%
41.96%
46.05%
48.12%
Total Expenditure
194.54
127.88
114.96
100.09
98.89
72.13
63.43
Power & Fuel Cost
-
5.15
4.25
2.90
3.01
2.26
3.31
% Of Sales
-
2.90%
2.77%
2.17%
2.35%
2.39%
3.99%
Employee Cost
-
30.15
18.82
15.81
14.26
12.74
11.61
% Of Sales
-
16.98%
12.27%
11.86%
11.12%
13.45%
13.99%
Manufacturing Exp.
-
0.83
1.34
0.81
1.24
1.20
1.64
% Of Sales
-
0.47%
0.87%
0.61%
0.97%
1.27%
1.98%
General & Admin Exp.
-
5.40
4.22
3.65
3.43
2.87
2.68
% Of Sales
-
3.04%
2.75%
2.74%
2.67%
3.03%
3.23%
Selling & Distn. Exp.
-
3.26
2.17
3.06
2.38
1.33
1.10
% Of Sales
-
1.84%
1.42%
2.29%
1.86%
1.40%
1.33%
Miscellaneous Exp.
-
0.83
0.49
0.32
0.15
0.61
0.04
% Of Sales
-
0.47%
0.32%
0.24%
0.12%
0.64%
0.05%
EBITDA
77.43
49.70
38.39
33.27
29.34
22.61
19.55
EBITDA Margin
28.47%
27.99%
25.03%
24.95%
22.88%
23.87%
23.56%
Other Income
3.44
1.31
3.18
4.67
2.17
1.18
2.02
Interest
7.38
8.55
7.62
5.96
2.91
2.49
2.26
Depreciation
24.53
20.88
18.05
14.99
9.67
8.06
7.08
PBT
48.95
21.58
15.90
16.99
18.93
13.23
12.23
Tax
12.85
4.03
4.23
4.23
3.75
2.55
2.60
Tax Rate
26.25%
18.72%
26.60%
24.90%
19.81%
19.27%
21.26%
PAT
36.11
17.50
11.67
12.76
15.18
10.68
9.62
PAT before Minority Interest
36.11
17.50
11.67
12.76
15.18
10.68
9.62
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
13.28%
9.85%
7.61%
9.57%
11.84%
11.27%
11.59%
PAT Growth
82.74%
49.96%
-8.54%
-15.94%
42.13%
11.02%
 
EPS
16.27
7.88
5.26
5.75
6.84
4.81
4.33

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Shareholder's Funds
285.48
262.33
173.35
127.45
98.45
81.32
Share Capital
21.95
21.75
19.04
17.12
15.62
14.96
Total Reserves
260.65
235.78
154.31
110.33
82.83
66.36
Non-Current Liabilities
66.60
67.27
108.50
93.54
46.07
19.57
Secured Loans
53.58
52.30
93.17
79.93
35.04
8.79
Unsecured Loans
0.01
2.65
5.05
5.07
3.41
3.68
Long Term Provisions
2.66
2.29
1.70
1.44
0.79
0.70
Current Liabilities
63.19
59.06
54.49
46.78
33.27
14.15
Trade Payables
21.07
27.45
26.09
30.50
19.78
5.44
Other Current Liabilities
19.43
16.30
13.58
8.57
8.82
4.98
Short Term Borrowings
21.36
13.88
13.02
4.52
1.69
2.18
Short Term Provisions
1.33
1.43
1.80
3.19
2.97
1.55
Total Liabilities
415.27
388.66
336.34
267.77
177.79
115.04
Net Block
308.96
314.29
266.64
204.65
69.10
65.69
Gross Block
386.10
370.69
304.99
235.50
90.28
78.81
Accumulated Depreciation
77.14
56.40
38.35
30.84
21.18
13.12
Non Current Assets
326.53
317.05
280.42
217.74
144.07
93.46
Capital Work in Progress
16.70
0.32
6.45
1.23
48.92
13.10
Non Current Investment
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Adv.
0.87
2.44
7.33
11.86
26.05
14.68
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
88.73
71.61
55.92
50.02
33.72
21.58
Current Investments
0.00
0.00
3.43
7.11
0.00
0.00
Inventories
43.59
27.73
15.40
14.18
15.70
10.93
Sundry Debtors
30.72
20.91
22.08
14.18
12.37
8.23
Cash & Bank
0.31
0.47
0.09
0.03
0.08
0.30
Other Current Assets
14.10
0.85
0.46
0.22
5.57
2.12
Short Term Loans & Adv.
13.76
21.65
14.46
14.30
5.48
2.04
Net Current Assets
25.54
12.55
1.42
3.25
0.45
7.42
Total Assets
415.26
388.66
336.34
267.76
177.79
115.04

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Cash From Operating Activity
34.03
24.47
33.34
35.70
14.58
18.86
PBT
21.53
15.90
16.88
18.93
13.23
12.23
Adjustment
28.96
24.90
20.14
12.50
8.90
9.19
Changes in Working Capital
-14.08
-13.18
0.60
4.09
-6.83
0.22
Cash after chg. in Working capital
36.41
27.62
37.61
35.52
15.30
21.64
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-2.37
-3.15
-4.27
0.18
-0.73
-2.77
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-30.71
-51.54
-74.38
-90.37
-46.83
-22.41
Net Fixed Assets
-31.79
-59.57
-74.71
-97.53
-47.29
Net Investments
0.00
3.43
3.68
-7.11
0.00
Others
1.08
4.60
-3.35
14.27
0.46
Cash from Financing Activity
-3.48
27.44
41.10
54.62
32.03
3.48
Net Cash Inflow / Outflow
-0.16
0.37
0.06
-0.05
-0.22
-0.06
Opening Cash & Equivalents
0.47
0.09
0.03
0.08
0.31
0.37
Closing Cash & Equivalent
0.31
0.47
0.09
0.03
0.08
0.31

Financial Ratios

Standalone /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Book Value (Rs.)
128.75
118.41
91.04
74.45
63.04
54.35
ROA
4.35%
3.22%
4.22%
6.81%
7.30%
8.36%
ROE
6.48%
5.42%
8.48%
13.44%
11.88%
11.83%
ROCE
8.43%
7.42%
8.95%
12.09%
13.16%
14.79%
Fixed Asset Turnover
0.47
0.45
0.49
0.79
1.12
1.05
Receivable days
53.06
51.16
49.62
37.80
39.70
36.22
Inventory Days
73.30
51.33
40.48
42.53
51.30
48.09
Payable days
107.64
116.77
140.43
123.30
90.05
46.13
Cash Conversion Cycle
18.72
-14.29
-50.33
-42.97
0.95
38.18
Total Debt/Equity
0.31
0.31
0.69
0.73
0.43
0.20
Interest Cover
3.52
3.09
3.85
7.51
6.30
6.41

Annual Reports:

FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017

News Update:


  • Sakar Healthcare - Quarterly Results
    25th Jul 2026, 00:00 AM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.